Stem Cell Therapy for Parkinson’s Disease.
Parkinson's disease Stem Cell Treatment
Stem cell therapy aims to replace damaged neurons, potentially restoring motor function and slowing disease progression.
Stem Cell Therapy for Parkinson's disease
Stem cell therapy for Parkinson’s disease offers the potential to replace the damaged or lost dopamine-producing neurons that cause the disease’s characteristic motor symptoms, such as tremors, stiffness, and slowed movement. By transplanting healthy stem cells that can develop into dopamine-producing neurons, the therapy aims to restore normal brain function and alleviate symptoms. While still in experimental stages, stem cell therapy holds promise for slowing disease progression and improving quality of life for those with Parkinson’s.
Parkinson’s disease
Stem cell therapy offers a promising avenue for treating Parkinson’s disease by addressing its root cause—loss of dopamine-producing neurons in the brain. Parkinson’s is a neurodegenerative disorder characterized by tremors, muscle stiffness, slowed movement, and impaired balance. As dopamine levels decline due to neuronal damage, these symptoms progressively worsen.
Stem cell therapy works by using mesenchymal stem cells, derived from the tissue of full-term human umbilical cords, which have the ability to differentiate into various types of cells. In the case of Parkinson’s disease, these stem cells are coaxed to develop into dopamine-producing neurons. Once transplanted into the brain, the hope is that these new neurons will replace the damaged ones, restoring dopamine production and improving motor function.
In addition to potentially reversing some of the damage, stem cell therapy could offer long-term benefits by slowing or even halting disease progression. Current treatments, such as medications and deep brain stimulation, primarily manage symptoms but do not address the underlying degeneration of neurons. Stem cell therapy, on the other hand, could be a more fundamental treatment that tackles the disease at its core.
While still in the research and clinical trial phases, early studies have shown promise. Stem cell therapy for Parkinson’s could lead to more effective, lasting treatment options, improving both quality of life and mobility for patients living with the disease.
Find the new you
ODIN Parkinson’s disease Procedure
ODIN STEM CELLS utilizes mesenchymal stem cells derived from the tissue of full-term human umbilical cords, ethically sourced and without the use of embryonic cells. Stem cell therapy for Parkinson’s disease involves several steps. First, stem cells are sourced from embryonic tissues or reprogrammed adult cells and then guided in the lab to become dopamine-producing neurons. The patient undergoes a thorough evaluation to determine suitability for the procedure. During the neurosurgical intervention, these prepared stem cells are precisely injected into specific brain regions affected by Parkinson’s, such as the putamen or substantia nigra. Post-procedure, patients are monitored for effectiveness and potential side effects, with ongoing assessments to track the survival and integration of the transplanted cells. This therapy aims to restore dopamine production and improve motor function, offering a potential advancement over current symptom management strategies.
How Stem cellS work
Stem cells are basic cells that can turn into different types of cells when needed by the body. They can either multiply or change into specific cell types, making them useful for many purposes.
Umbilical Cord Stem Cell Therapy
Umbilical cord stem cell therapy is gaining attention for its potential to treat a wide range of medical conditions. This approach is showing promise in regenerative medicine and is being explored for various uses, offering hope for innovative treatments and improved outcomes.
Why Choose Odin Clinic?
Book a call with one of our doctors.
Discover how stem cell therapy can help you. Speak directly with one of our doctors today and start your path to living a better life.
